Celiac disease (CD) is a chronic autoimmune enteropathy based on
intolerance to gluten present in wheat, barley, oats, and rye. Patients present
an intestinal inflammatory process and difficulty absorbing nutrients.
Diagnosis is based on a blood test to detect antibodies; however, the gold
standard is an intestinal biopsies. Therefore, our goal is to find new and
minimally invasive biomarkers that complement the detection of antibodies,
thereby improving the diagnosis, prognosis, and monitoring of CD.